staurosporine has been researched along with 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elkamhawy, A; Farag, AK; Lee, KT; Londhe, AM; Pae, AN; Roh, EJ | 1 |
1 other study(ies) available for staurosporine and 3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one
Article | Year |
---|---|
Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cell Survival; Dose-Response Relationship, Drug; Inflammation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Pyrimidines; RAW 264.7 Cells; Receptors, Colony-Stimulating Factor; Structure-Activity Relationship | 2017 |